Related Experiment Video

Updated: May 5, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.2K

Reimagining the N-Of-1 Trial Within Pediatric Neuro-Oncology: A Shifting Paradigm

Rafael Uribe-Cardenas1, Jeffrey P Greenfield1

  • 1Department of Neurological Surgery, NewYork-Presbyterian Weill Cornell Medicine, New York, New York, USA.

World Neurosurgery
|October 19, 2024
PubMed

Insights

Advances in neuro-oncology offer personalized treatments for rare pediatric brain tumors. Precision medicine enables tailored therapies, improving patient outcomes by treating each individual as their own clinical trial.

Area of Science:

  • Neuro-oncology
  • Pediatric oncology
  • Precision medicine

Background:

  • Significant advances in neuro-oncology have expanded treatment options.
  • Overall outcomes for high-grade brain tumors remain suboptimal.
  • The rarity of pediatric brain tumors hinders large-scale clinical trials.

Purpose of the Study:

  • To explore the potential of precision medicine in neuro-oncology.
  • To address the challenges posed by rare pediatric brain tumors.
  • To propose new clinical trial paradigms for neuro-oncology.

Main Methods:

  • Leveraging genetic and molecular testing for personalized treatment strategies.
  • Utilizing a precision medicine approach where each patient is their own control.
  • Monitoring disease progression through single-patient testing.

Main Results:

  • Precision medicine offers tailored treatment at every disease stage.
  • Individualized testing allows for directed therapies.
  • This approach represents a paradigm shift in neuro-oncology.

Conclusions:

  • Precision medicine holds promise for improving outcomes in pediatric neuro-oncology.
  • Personalized treatment strategies can overcome limitations of traditional clinical trials.
  • Further integration of these technologies into standard care is needed.
Keywords:
Clinical trialsNeuro-oncologyPrecision medicine

More Related Videos

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.1K
Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

2.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K